Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -4.68% is 92% above its 5-year average of -57.31%, near the high end of its 5-year range (-87.96%–-4.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 92.75% above its 12-month average of -64.51%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -4.68%.
RETURN ON EQUITY (ROE)
-4.68%
RETURN ON EQUITY (ROE) AVG TTM
-64.51%
RETURN ON EQUITY (ROE) AVG 3Y
-66.26%
RETURN ON EQUITY (ROE) AVG 5Y
-57.31%
RETURN ON EQUITY (ROE) AVG 10Y
-49.78%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+92.75%
CURRENT VS 3Y AVG
+92.94%
CURRENT VS 5Y AVG
+91.84%
CURRENT VS 10Y AVG
+90.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-41.78%
median of 742 covered companies
CURRENT VS SECTOR MEDIAN
+88.81%
vs the sector median at left
Rocket Pharmaceuticals, Inc.
Market Cap
$270.25M
Return on Equity (ROE)
-4.68%
TTM Avg
-64.51%
3Y Avg
-66.26%
5Y Avg
-57.31%
Market Cap
$270.31M
Return on Equity (ROE)
-124.83%
TTM Avg
-35.45%
3Y Avg
-17.31%
5Y Avg
-9.59%
Market Cap
$269.87M
Return on Equity (ROE)
-87.86%
TTM Avg
-58.47%
3Y Avg
-55.90%
5Y Avg
-119.72%
Market Cap
$269.40M
Return on Equity (ROE)
-5.95%
TTM Avg
-61.29%
3Y Avg
-64.14%
5Y Avg
-41.58%
Market Cap
$272.17M
Return on Equity (ROE)
-82.12%
TTM Avg
-62.12%
3Y Avg
-56.53%
5Y Avg
-50.41%
Market Cap
$267.85M
Return on Equity (ROE)
-430.72%
TTM Avg
122.09%
3Y Avg
211.60%
5Y Avg
136.09%
Market Cap
$265.87M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$263.68M
Return on Equity (ROE)
-184.27%
TTM Avg
-57.34%
3Y Avg
-61.84%
5Y Avg
-87.31%
Market Cap
$262.92M
Return on Equity (ROE)
-39.55%
TTM Avg
-28.46%
3Y Avg
-79.02%
5Y Avg
-63.95%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals, Inc. (RCKT) | $270.25M | -4.68% | -64.51% | -66.26% | -57.31% |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $270.31M | -124.83% | -35.45% | -17.31% | -9.59% |
| Treace Medical Concepts, Inc. (TMCI)vs › | $269.87M | -87.86% | -58.47% | -55.90% | -119.72% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $269.40M | -5.95% | -61.29% | -64.14% | -41.58% |
| Fate Therapeutics, Inc. (FATE)vs › | $272.17M | -82.12% | -62.12% | -56.53% | -50.41% |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $267.85M | -430.72% | 122.09% | 211.60% | 136.09% |
| Scribe Therapeutics Inc. (SCTX)vs › | $265.87M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | -184.27% | -57.34% | -61.84% | -87.31% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $262.92M | -39.55% | -28.46% | -79.02% | -63.95% |
| OraSure Technologies, Inc. (OSUR)vs › | $262.66M | -15.46% | -12.46% | -4.29% | -4.49% |
ROE
-4.7%
ROA
-4.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -4.68% |
| 2026-03-31 | -87.96% |
| 2025-12-31 | -80.49% |
| 2025-09-30 | -76.80% |
| 2025-06-30 | -72.64% |
| 2025-03-31 | -62.61% |
| 2024-12-31 | -55.86% |
| 2024-09-30 | -78.26% |
| 2024-06-30 | -65.84% |
| 2024-03-31 | -56.47% |
| 2023-12-31 | -49.86% |
| 2023-09-30 | -46.69% |
| 2023-06-30 | -61.67% |
| 2023-03-31 | -51.70% |
| 2022-12-31 | -45.31% |
| 2022-09-30 | -54.28% |
| 2022-06-30 | -49.46% |
| 2022-03-31 | -41.16% |
| 2021-12-31 | -37.18% |
| 2021-09-30 | -38.24% |
| 2021-06-30 | -33.65% |
| 2021-03-31 | -32.34% |
| 2020-12-31 | -27.74% |
| 2020-09-30 | -40.79% |
| 2020-06-30 | -33.33% |
| 2020-03-31 | -28.84% |
| 2019-12-31 | -25.15% |
| 2019-09-30 | -36.54% |
| 2019-06-30 | -32.81% |
| 2019-03-31 | -44.40% |
| 2018-12-31 | -38.40% |
| 2018-09-30 | -36.25% |
| 2018-06-30 | -27.61% |
| 2018-03-31 | -20.08% |
| 2017-12-31 | -61.76% |
| 2017-09-30 | -73.62% |
| 2017-06-30 | -71.85% |
| 2017-03-31 | -68.69% |
| 2016-12-31 | -58.57% |
| 2016-09-30 | -44.74% |
| 2016-06-30 | -86.84% |
| 2016-03-31 | -77.17% |
| 2015-12-31 | -62.48% |
| 2015-09-30 | -53.19% |
| 2015-06-30 | -26.44% |
| 2015-03-31 | -26.05% |
